Prestige Brands Holdings Inc. is acquiring fellow competitor C.B. Fleet Co. in an $825 million all-cash deal.
The move will help bolster Prestige's women's health, gastrointestinal and pediatric care portfolio, and is expected to add approximately $1 billion in pro forma revenues in fiscal 2018.
C.B. Fleet's portfolio is anchored by the Summer's Eve product.
The deal is expected to close by the end of the fiscal fourth quarter of 2017 with Barclays acting as the exclusive financial adviser to Prestige.